CSBR:NASDAQ
Champions Oncology Inc
US$4,34
arrow_downward
-1,36%(-0,060) 1D
20 ພ.ຈ., 16 ໂມງ 0 ນາທີ 00 ວິນາທີ GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
US$4,45
High
US$4,45
Low
US$4,34
Mkt. cap
60,41 ລ້ານ
Avg. vol.
6,97 ພັນ
Volume
8,94 ພັນ
52-wk high
US$8,31
52-wk low
US$4,34
EPS
US$-0,08
Beta
0,47
Shares outstanding
13,92 ລ້ານ
No. of employees
217
Open
US$4,45
High
US$4,45
Low
US$4,34
Mkt. cap
60,41 ລ້ານ
Avg. vol.
6,97 ພັນ
Volume
8,94 ພັນ
52-wk high
US$8,31
52-wk low
US$4,34
EPS
US$-0,08
Beta
0,47
Shares outstanding
13,92 ລ້ານ
No. of employees
217
News stories
From web sources and news partners
AP News
·
16 ຊົ່ວໂມງກ່ອນ
S&P 500 sinks 3.7% and Nasdaq composite goes negative for the year as tech sell-off worsens
24/7 Wall St.
·
8 ນາທີກ່ອນ
Jim Cramer Says the Market “Sliced Right Through” His S&P 500 Target
Trefis
·
7 ຊົ່ວໂມງກ່ອນ
S&P 500 Movers | Winners: GPN, GIS, MKC | Losers: BE, NVDA, LITE
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersHackensack, ນິວເຈີຊີ, ສະຫະລັດ
SectorHealth Care
Industry-
Websitechampionsoncology.com